— Know what they know.
Not Investment Advice
Also trades as: BSX-PA (NYSE) · $vol 22M · 0HOY.L (LSE) · $vol 2M · BSX.F (FSX) · $vol 0M

BSX NYSE

Boston Scientific Corporation
1W: +6.7% 1M: -11.9% 3M: -23.4% YTD: -39.7% 1Y: -46.4% 3Y: +6.3% 5Y: +37.5%
$57.78
+0.63 (+1.10%)
After Hours: $57.31 (-0.47, -0.81%)
Weekly Expected Move ±7.1%
$45 $49 $53 $56 $60
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 53 · $85.9B mcap · 1.48B float · 1.12% daily turnover · Short 29% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
63.4 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 11.4%  ·  5Y Avg: 6.3%
Cost Advantage
58
Intangibles
65
Switching Cost
52
Network Effect
75
Scale
75
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BSX has a Narrow competitive edge (63.4/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 11.4% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$60
Low
$83
Avg Target
$100
High
Based on 12 analysts since Apr 22, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 39Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$84.31
Analysts16
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-19 Robert W. Baird $78 $75 -3 +34.1% $55.92
2026-04-28 Daiwa Initiated $60 +2.7% $58.45
2026-04-23 RBC Capital $115 $100 -15 +52.0% $65.80
2026-04-23 Oppenheimer $100 $90 -10 +36.9% $65.72
2026-04-23 Canaccord Genuity William Plovanic $109 $71 -38 +9.4% $64.87
2026-04-23 Needham Mike Matson $97 $77 -20 +18.7% $64.87
2026-04-23 Truist Financial $90 $85 -5 +31.0% $64.87
2026-04-23 Robert W. Baird $101 $78 -23 +20.2% $64.87
2026-04-23 Wells Fargo $94 $75 -19 +15.6% $64.87
2026-04-23 Barclays Matt Miksic $124 $96 -28 +48.0% $64.87
2026-04-22 Goldman Sachs David Roman $93 $84 -9 +29.5% $64.87
2026-04-22 Jefferies Matthew Taylor Initiated $100 +54.2% $64.87
2026-04-21 Stifel Nicolaus Rick Wise $110 $85 -25 +39.4% $60.99
2026-04-15 Truist Financial $95 $90 -5 +38.6% $64.92
2026-04-13 Mizuho Securities $115 $90 -25 +45.0% $62.06
2026-03-26 Goldman Sachs $99 $93 -6 +32.5% $70.17
2026-02-17 Canaccord Genuity William Plovanic $112 $109 -3 +45.9% $74.73
2026-02-06 Bernstein Lee Hambright Initiated $112 +44.6% $77.46
2026-02-05 Truist Financial $120 $95 -25 +23.3% $77.02
2026-02-05 RBC Capital $130 $115 -15 +49.0% $77.17
2026-02-05 Needham $53 $97 +44 +28.4% $75.52
2026-02-05 Mizuho Securities $85 $115 +30 +52.7% $75.29
2026-02-05 Evercore ISI $112 $96 -16 +26.9% $75.64
2026-02-05 Wells Fargo $125 $94 -31 +24.5% $75.50
2026-02-05 Goldman Sachs $112 $99 -13 +31.1% $75.50
2026-02-05 Robert W. Baird $128 $101 -27 +33.8% $75.50
2026-02-05 UBS $140 $120 -20 +58.9% $75.50
2026-02-05 Canaccord Genuity William Plovanic $131 $112 -19 +48.3% $75.50
2026-02-04 Stifel Nicolaus Rick Wise $100 $110 +10 +45.7% $75.50
2026-02-04 BTIG $132 $110 -22 +45.5% $75.61
2026-02-03 Barclays $136 $124 -12 +35.0% $91.87
2026-02-02 National Bank Initiated $115 +23.5% $93.13
2026-01-16 Oppenheimer $125 $100 -25 +11.1% $90.03
2026-01-09 Goldman Sachs David Roman $124 $112 -12 +13.8% $98.38
2026-01-05 Evercore ISI $110 $112 +2 +17.7% $95.15
2025-12-18 Truist Financial $130 $120 -10 +24.3% $96.56
2025-12-17 RBC Capital $98 $130 +32 +39.9% $92.95
2025-12-17 Canaccord Genuity William Plovanic $132 $131 -1 +40.9% $92.95
2025-10-23 Truist Financial $129 $130 +1 +25.6% $103.53
2025-10-23 Morgan Stanley Patrick Wood $56 $130 +74 +25.2% $103.85
2025-10-23 UBS $118 $140 +22 +34.3% $104.23
2025-10-23 Wells Fargo $82 $125 +43 +19.9% $104.23
2025-10-22 Goldman Sachs $90 $124 +34 +19.4% $103.85
2025-10-07 Evercore ISI $100 $110 +10 +13.8% $96.70
2025-10-02 Barclays Initiated $136 +41.9% $95.85
2025-10-01 Truist Financial Richard Newitter $117 $129 +12 +37.0% $94.15
2025-10-01 BTIG $124 $132 +8 +35.2% $97.63
2025-10-01 Robert W. Baird $100 $128 +28 +31.1% $97.63
2025-10-01 Canaccord Genuity $98 $132 +34 +35.2% $97.63
2025-09-08 Oppenheimer Suraj Kalia $77 $125 +48 +15.6% $108.14

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
5
ROE
4
ROA
5
D/E
2
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BSX receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-08 B+ A-
2026-05-05 C B+
2026-04-23 B C
2026-02-19 C- B
2026-02-05 B C-
2026-01-28 C- B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

73 Grade A+
Profitability
73
Balance Sheet
64
Earnings Quality
81
Growth
71
Value
41
Momentum
95
Safety
90
Cash Flow
65
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BSX scores highest in Momentum (95/100) and lowest in Value (41/100). An overall grade of A+ places BSX among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.98
Safe Zone
Piotroski F-Score
8/9
Beneish M-Score
-2.47
Unlikely Manipulator
Ohlson O-Score
-9.45
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 80.0/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.22x
Accruals: -1.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BSX scores 3.98, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BSX scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BSX's score of -2.47 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BSX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BSX receives an estimated rating of AA- (score: 80.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). BSX's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
24.01x
PEG
0.32x
P/S
4.14x
P/B
3.30x
P/FCF
27.25x
P/OCF
21.61x
EV/EBITDA
21.87x
EV/Revenue
5.05x
EV/EBIT
25.50x
EV/FCF
30.27x
Earnings Yield
3.79%
FCF Yield
3.67%
Shareholder Yield
0.00%
Graham Number
$29.44
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 24.0x earnings, BSX commands a growth premium. Graham's intrinsic value formula yields $29.44 per share, 96% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.949
NI / EBT
×
Interest Burden
0.916
EBT / EBIT
×
EBIT Margin
0.198
EBIT / Rev
×
Asset Turnover
0.496
Rev / Assets
×
Equity Multiplier
1.806
Assets / Equity
=
ROE
15.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BSX's ROE of 15.4% is driven by Asset Turnover (0.496), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.95 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
56.18%
Fair P/E
120.87x
Intrinsic Value
$287.26
Price/Value
0.22x
Margin of Safety
78.16%
Premium
-78.16%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with BSX's realized 56.2% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $287.26, BSX appears undervalued with a 78% margin of safety. The adjusted fair P/E of 120.9x compares to the current market P/E of 24.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$57.75
Median 1Y
$58.90
5th Pctile
$36.17
95th Pctile
$96.04
Ann. Volatility
28.6%
Analyst Target
$84.31
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Michael F. Mahoney
Chairman of the Board, President and Chief Executive Officer
$1,442,603 $13,608,056 $23,532,050
Joseph M. Fitzgerald
Executive Vice President and Group President, Cardiovascular
$892,604 $4,309,282 $8,042,997
Arthur C. Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific
$744,822 $3,447,272 $6,534,719
Daniel J. Brennan
Former Executive Vice President and Chief Financial Officer
$660,990 $3,447,272 $6,282,896
Jonathan R. Monson
Executive Vice President and Chief Financial Officer
$591,848 $1,624,898 $6,083,679
Jeffrey B. Mirviss
Executive Vice President and President, Peripheral Interventions
$702,042 $1,995,566 $4,159,959
Vance R. Brown
Senior Vice President, General Counsel and Corporate Secretary
$659,086 $1,723,636 $3,920,644

CEO Pay Ratio

202:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $23,532,050
Avg Employee Cost (SGA/emp): $116,729
Employees: 59,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
59,000
+11.3% YoY
Revenue / Employee
$340,237
Rev: $20,074,000,000
Profit / Employee
$48,915
NI: $2,886,000,000
SGA / Employee
$116,729
Avg labor cost proxy
R&D / Employee
$34,780
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 3.6% 7.5% 6.5% 5.1% 5.5% 4.1% 4.1% 5.3% 5.3% 7.2% 8.6% 9.6% 9.9% 9.7% 9.0% 9.9% 12.2% 13.6% 12.6% 15.4% 15.45%
ROA 1.7% 3.6% 3.3% 2.6% 2.8% 2.1% 2.2% 2.8% 2.8% 3.8% 4.7% 5.2% 5.4% 5.3% 5.0% 5.5% 6.7% 7.5% 7.0% 8.6% 8.55%
ROIC 6.0% 5.9% 7.1% 6.9% 6.1% 5.8% 4.4% 4.6% 4.6% 5.2% 6.3% 6.8% 7.6% 7.6% 6.6% 7.3% 7.6% 8.8% 9.8% 11.4% 11.39%
ROCE 3.2% 5.8% 5.1% 5.2% 5.9% 4.9% 5.7% 5.9% 6.2% 7.5% 7.5% 8.0% 8.0% 8.3% 8.0% 8.7% 10.3% 11.1% 10.2% 10.7% 10.69%
Gross Margin 63.1% 62.5% 62.1% 60.9% 61.3% 60.8% 60.3% 61.3% 63.2% 61.4% 62.1% 61.8% 62.7% 62.9% 58.6% 63.3% 67.7% 69.9% 74.5% 69.4% 69.44%
Operating Margin 16.6% 15.1% 14.6% 15.1% 14.7% 14.5% 13.8% 15.2% 15.3% 15.8% 15.0% 16.7% 18.1% 16.0% 12.9% 19.2% 16.2% 20.7% 22.8% 20.6% 20.60%
Net Margin 6.0% 14.3% 3.0% 3.7% 8.0% 5.9% 4.3% 9.3% 7.5% 14.3% 13.5% 12.8% 7.9% 11.1% 12.4% 14.5% 15.7% 14.9% 12.6% 25.7% 25.70%
EBITDA Margin 16.2% 28.7% 15.9% 24.0% 21.3% 18.7% 23.3% 23.5% 22.1% 27.7% 23.8% 25.5% 19.7% 25.1% 23.5% 26.1% 27.0% 27.0% 18.1% 20.6% 20.60%
FCF Margin 15.7% 14.1% 11.1% 7.5% 4.7% 4.2% 7.2% 9.0% 10.6% 11.8% 12.0% 10.6% 11.6% 12.4% 14.6% 16.4% 17.9% 19.5% 18.1% 16.7% 16.70%
OCF Margin 20.0% 18.0% 15.7% 12.6% 9.7% 9.5% 12.0% 13.6% 15.9% 17.1% 17.6% 16.8% 17.3% 18.5% 20.5% 21.7% 23.2% 23.9% 22.6% 21.1% 21.06%
ROE 3Y Avg snapshot only 11.06%
ROE 5Y Avg snapshot only 8.64%
ROA 3Y Avg snapshot only 6.11%
ROIC 3Y Avg snapshot only 7.98%
ROIC Economic snapshot only 10.88%
Cash ROA snapshot only 9.94%
Cash ROIC snapshot only 12.54%
CROIC snapshot only 9.95%
NOPAT Margin snapshot only 19.13%
Pretax Margin snapshot only 18.15%
R&D / Revenue snapshot only 10.31%
SGA / Revenue snapshot only 34.31%
SBC / Revenue snapshot only 0.75%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 116.90 56.73 58.66 78.65 60.62 85.41 95.48 80.20 86.37 63.42 53.63 57.27 62.59 69.59 71.83 74.09 64.11 52.37 49.35 26.40 24.014
P/S Ratio 5.47 5.43 5.13 5.24 4.35 4.44 5.26 5.55 5.88 5.66 6.00 6.90 7.51 7.83 7.95 8.58 8.67 7.55 7.10 4.55 4.143
P/B Ratio 4.00 4.06 3.67 3.83 3.22 3.36 3.80 4.12 4.48 4.43 4.43 5.26 5.93 6.46 6.11 6.92 7.37 6.71 5.89 3.87 3.299
P/FCF 34.94 38.50 46.36 69.40 91.92 106.64 72.70 61.52 55.24 48.07 50.13 65.35 64.98 63.43 54.60 52.43 48.44 38.68 39.34 27.25 27.255
P/OCF 27.31 30.16 32.63 41.69 44.99 46.59 43.74 40.78 37.05 33.10 34.11 40.97 43.43 42.45 38.75 39.51 37.43 31.56 31.46 21.61 21.611
EV/EBITDA 35.23 26.39 27.19 27.78 22.17 25.24 27.14 28.43 29.62 25.94 27.23 30.25 33.61 35.64 36.65 38.81 36.31 31.20 31.17 21.87 21.874
EV/Revenue 6.17 6.11 5.77 5.86 4.96 5.04 5.92 6.19 6.50 6.27 6.60 7.49 8.07 8.38 8.59 9.19 9.25 8.10 7.62 5.05 5.054
EV/EBIT 80.39 44.82 47.99 48.62 37.36 46.00 46.04 47.72 48.94 40.18 41.69 45.42 50.63 53.22 54.18 56.28 50.36 42.67 39.17 25.50 25.498
EV/FCF 39.39 43.32 52.08 77.60 104.82 121.03 81.80 68.62 61.09 53.23 55.20 70.90 69.88 67.82 59.00 56.16 51.68 41.52 42.21 30.27 30.269
Earnings Yield 0.9% 1.8% 1.7% 1.3% 1.6% 1.2% 1.0% 1.2% 1.2% 1.6% 1.9% 1.7% 1.6% 1.4% 1.4% 1.3% 1.6% 1.9% 2.0% 3.8% 3.79%
FCF Yield 2.9% 2.6% 2.2% 1.4% 1.1% 0.9% 1.4% 1.6% 1.8% 2.1% 2.0% 1.5% 1.5% 1.6% 1.8% 1.9% 2.1% 2.6% 2.5% 3.7% 3.67%
PEG Ratio snapshot only 0.325
EV/OCF snapshot only 24.000
EV/Gross Profit snapshot only 7.177
Acquirers Multiple snapshot only 25.123
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $29.44
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.82 1.82 1.48 1.48 1.48 1.48 1.51 1.51 1.51 1.51 1.32 1.32 1.32 1.32 1.08 1.08 1.08 1.08 1.62 1.62 1.617
Quick Ratio 1.45 1.45 1.10 1.10 1.10 1.10 1.02 1.02 1.02 1.02 0.82 0.82 0.82 0.82 0.64 0.64 0.64 0.64 1.08 1.08 1.076
Debt/Equity 0.62 0.62 0.57 0.57 0.57 0.57 0.53 0.53 0.53 0.53 0.49 0.49 0.49 0.49 0.51 0.51 0.51 0.51 0.51 0.51 0.512
Net Debt/Equity 0.51 0.51 0.45 0.45 0.45 0.45 0.48 0.48 0.48 0.48 0.45 0.45 0.45 0.45 0.49 0.49 0.49 0.49 0.43 0.43 0.428
Debt/Assets 0.31 0.31 0.29 0.29 0.29 0.29 0.29 0.29 0.29 0.29 0.27 0.27 0.27 0.27 0.28 0.28 0.28 0.28 0.28 0.28 0.284
Debt/EBITDA 4.87 3.59 3.75 3.69 3.43 3.77 3.35 3.27 3.16 2.79 2.75 2.61 2.60 2.54 2.84 2.68 2.37 2.22 2.53 2.61 2.607
Net Debt/EBITDA 3.98 2.94 2.99 2.94 2.73 3.00 3.02 2.94 2.84 2.51 2.50 2.37 2.36 2.31 2.73 2.58 2.28 2.14 2.11 2.18 2.178
Interest Coverage 2.36 4.36 4.07 2.63 3.07 2.69 3.34 6.50 6.67 7.98 8.29 8.75 8.46 8.26 7.08 7.35 8.52 9.11 11.03 11.45 11.445
Equity Multiplier 2.01 2.01 1.94 1.94 1.94 1.94 1.85 1.85 1.85 1.85 1.82 1.82 1.82 1.82 1.81 1.81 1.81 1.81 1.80 1.80 1.802
Cash Ratio snapshot only 0.376
Debt Service Coverage snapshot only 13.342
Cash to Debt snapshot only 0.165
FCF to Debt snapshot only 0.277
Defensive Interval snapshot only 175.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.37 0.37 0.38 0.39 0.39 0.40 0.39 0.40 0.41 0.43 0.42 0.44 0.45 0.47 0.45 0.47 0.50 0.52 0.48 0.50 0.496
Inventory Turnover 3.08 3.09 3.04 3.11 3.19 3.29 2.86 2.93 2.97 3.04 2.49 2.56 2.66 2.75 2.44 2.53 2.57 2.55 2.16 2.12 2.120
Receivables Turnover 6.67 6.83 7.19 7.35 7.45 7.60 6.77 6.96 7.15 7.34 6.78 7.01 7.25 7.58 7.00 7.34 7.73 8.09 7.32 7.52 7.518
Payables Turnover 8.56 8.58 6.90 7.05 7.23 7.45 6.00 6.16 6.24 6.38 6.00 6.17 6.41 6.63 6.79 7.04 7.15 7.11 5.91 5.80 5.798
DSO 55 53 51 50 49 48 54 52 51 50 54 52 50 48 52 50 47 45 50 49 48.5 days
DIO 118 118 120 117 114 111 128 124 123 120 147 143 137 133 150 144 142 143 169 172 172.2 days
DPO 43 43 53 52 50 49 61 59 59 57 61 59 57 55 54 52 51 51 62 63 63.0 days
Cash Conversion Cycle 131 129 118 115 113 110 121 118 115 113 140 136 131 126 148 142 138 137 157 158 157.8 days
Fixed Asset Turnover snapshot only 4.580
Operating Cycle snapshot only 220.8 days
Cash Velocity snapshot only 10.081
Capital Intensity snapshot only 2.119
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 10.2% 13.4% 19.9% 20.2% 10.1% 9.6% 6.7% 7.3% 8.7% 9.5% 12.3% 12.7% 13.6% 15.7% 17.6% 19.4% 21.4% 21.6% 19.9% 17.4% 17.44%
Net Income -86.9% -70.4% 8.5% 3.2% 68.7% -40.5% -32.8% 11.4% 3.2% 88.1% 1.3% 96.5% 1.0% 45.8% 16.4% 14.7% 37.0% 55.7% 56.0% 74.8% 74.77%
EPS -87.1% -70.5% 8.5% 3.2% 68.1% -40.7% -33.1% 10.8% 1.9% 83.6% 1.2% 91.7% 96.4% 44.6% 15.4% 13.9% 36.2% 54.8% 55.4% 74.5% 74.54%
FCF 1.0% 62.8% 31.3% -34.0% -66.7% -67.7% -30.2% 28.1% 1.4% 2.1% 85.5% 32.1% 23.4% 21.3% 43.2% 85.0% 88.2% 92.1% 48.7% 19.8% 19.81%
EBITDA 29.5% 1.2% 85.2% 55.3% 40.6% -5.6% 9.8% 10.7% 6.7% 32.5% 24.8% 28.3% 24.3% 12.5% 13.7% 14.2% 28.9% 34.3% 25.0% 14.6% 14.55%
Op. Income 35.0% 78.5% 2.0% 1.5% 40.2% 24.5% 4.1% 1.8% 7.7% 12.0% 18.4% 21.6% 26.9% 26.5% 21.6% 25.7% 18.8% 27.9% 49.6% 42.7% 42.70%
OCF Growth snapshot only 13.88%
Asset Growth snapshot only 10.86%
Equity Growth snapshot only 11.31%
Debt Growth snapshot only 11.40%
Shares Change snapshot only 0.13%
Dividend Growth snapshot only -1.00%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 5.6% 5.9% 6.6% 7.0% 7.0% 6.5% 5.7% 6.5% 9.7% 10.8% 12.8% 13.3% 10.8% 11.5% 12.1% 13.0% 14.5% 15.5% 16.5% 16.5% 16.48%
Revenue 5Y 7.1% 7.0% 7.2% 7.2% 7.2% 7.3% 7.0% 7.1% 7.1% 7.3% 7.7% 8.2% 8.6% 8.9% 9.3% 10.2% 12.7% 13.9% 15.2% 15.3% 15.29%
EPS 3Y -0.6% 17.0% -15.2% -23.9% -14.7% -16.2% -47.4% -41.0% -39.5% -31.5% 1.1% 49.8% 16.3% 19.7% 34.2% 39.7% 60.2% 58.6% 56.2% 56.18%
EPS 5Y 67.1% 23.6% 12.5% 1.7% -5.6% 45.0% 50.7% 11.0% 11.8% -1.9% -1.3% 4.4% 9.3% -17.9% -14.8% -9.9% -6.4% 77.9% 77.87%
Net Income 3Y 0.2% 17.9% -14.6% -23.3% -14.1% -15.7% -47.0% -40.5% -38.8% -30.8% 1.1% 51.6% 17.7% 21.2% 35.9% 41.5% 62.2% 60.5% 57.9% 57.93%
Net Income 5Y 68.4% 24.5% 13.2% 2.3% -5.0% 46.4% 51.8% 11.8% 12.9% -1.0% -0.3% 5.5% 10.4% -17.0% -13.9% -8.9% -5.5% 79.4% 79.44%
EBITDA 3Y -5.2% 2.4% -0.8% -2.8% 1.5% 2.3% 7.8% 16.4% 24.8% 40.3% 36.4% 30.2% 23.1% 12.1% 15.9% 17.5% 19.6% 26.1% 21.1% 18.8% 18.84%
EBITDA 5Y 51.2% 21.1% 18.2% 8.9% 6.1% 6.6% 6.9% 5.0% 6.1% 6.0% 5.5% 6.7% 9.8% 12.2% 18.2% 25.5% 33.1% 29.2% 23.6% 23.60%
Gross Profit 3Y 2.2% 2.7% 4.4% 5.2% 5.1% 4.8% 4.1% 5.5% 10.8% 12.8% 16.6% 16.9% 12.2% 12.7% 11.7% 12.8% 15.4% 17.8% 21.5% 22.2% 22.24%
Gross Profit 5Y 3.8% 4.4% 5.6% 6.1% 6.2% 6.2% 5.6% 5.4% 5.6% 5.7% 6.4% 7.1% 7.6% 8.2% 8.5% 9.9% 14.1% 16.4% 20.0% 20.4% 20.44%
Op. Income 3Y -8.8% -5.4% 0.6% 3.0% 2.6% 3.3% 3.4% 9.2% 26.8% 35.5% 54.0% 46.5% 24.2% 20.8% 14.5% 15.9% 17.6% 21.9% 29.2% 29.7% 29.69%
Op. Income 5Y 1.3% 23.6% 24.3% 6.2% 5.8% 3.9% 2.6% 2.8% 3.3% 4.6% 6.2% 8.1% 9.3% 9.8% 14.8% 25.2% 32.1% 46.0% 41.3% 41.35%
FCF 3Y 36.6% 30.6% 1.3% -4.8% -6.8% -9.5% 13.7% 18.4% 17.7% 19.3% 3.8% 0.1% 6.7% 22.8% 46.3% 78.4% 93.3% 58.1% 43.0% 43.04%
FCF 5Y 12.3% 24.5% 17.2% 18.5% 17.5% -6.0% -5.3% -3.2% 15.7% 17.4% 83.3% 21.1% 25.0% 14.5% 29.1% 30.9% 30.6% 29.3% 19.9% 19.88%
OCF 3Y 26.3% 21.1% 82.0% 48.5% 0.8% 1.0% -6.0% 8.0% 15.3% 15.5% 18.4% 9.8% 5.5% 12.4% 22.5% 35.6% 53.2% 56.9% 43.8% 34.8% 34.76%
OCF 5Y 12.0% 19.9% 14.0% 12.5% 10.4% -0.2% -1.1% -0.4% 13.8% 15.1% 51.9% 39.6% 17.8% 20.3% 13.3% 22.0% 25.3% 24.8% 24.6% 18.4% 18.36%
Assets 3Y 17.4% 17.4% 15.4% 15.4% 15.4% 15.4% 2.0% 2.0% 2.0% 2.0% 4.5% 4.5% 4.5% 4.5% 6.9% 6.9% 6.9% 6.9% 10.4% 10.4% 10.39%
Assets 5Y 11.2% 11.2% 12.2% 12.2% 12.2% 12.2% 11.3% 11.3% 11.3% 11.3% 10.8% 10.8% 10.8% 10.8% 5.2% 5.2% 5.2% 5.2% 7.2% 7.2% 7.25%
Equity 3Y 29.8% 29.8% 24.0% 24.0% 24.0% 24.0% 8.2% 8.2% 8.2% 8.2% 8.0% 8.0% 8.0% 8.0% 9.4% 9.4% 9.4% 9.4% 11.3% 11.3% 11.30%
Book Value 3Y 28.8% 28.8% 23.1% 23.1% 23.1% 23.2% 7.5% 7.4% 7.1% 7.1% 7.1% 6.7% 6.7% 6.7% 8.1% 8.1% 8.0% 8.0% 10.0% 10.1% 10.07%
Dividend 3Y 57.6% 24.4% 8.6% -1.3% -1.2% -0.7% -0.8% -1.0% -10.2% -20.8% -37.4% -18.5% -7.5% 16.5%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.96 0.91 0.80 0.82 0.95 0.91 0.82 0.84 0.94 0.91 0.87 0.88 0.94 0.92 0.89 0.89 0.93 0.94 0.96 0.96 0.964
Earnings Stability 0.28 0.36 0.03 0.02 0.02 0.02 0.01 0.01 0.02 0.00 0.13 0.13 0.08 0.05 0.09 0.06 0.02 0.01 0.90 0.92 0.916
Margin Stability 0.93 0.94 0.93 0.94 0.96 0.96 0.95 0.95 0.96 0.95 0.94 0.95 0.97 0.98 0.98 0.99 0.98 0.96 0.93 0.92 0.920
Rev. Growth Consistency 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.20 0.50 0.50 0.84 0.50 0.95 0.99 0.50 0.50 0.50 0.50 0.82 0.93 0.94 0.85 0.50 0.50 0.50 0.500
Earnings Smoothness 0.00 0.00 0.00 0.49 0.49 0.61 0.89 0.97 0.39 0.22 0.35 0.33 0.63 0.85 0.86 0.69 0.56 0.56 0.46 0.456
ROE Trend -0.19 -0.12 -0.10 -0.11 -0.11 -0.13 0.01 0.02 0.01 0.01 0.03 0.04 0.04 0.04 0.02 0.02 0.04 0.05 0.04 0.05 0.054
Gross Margin Trend -0.03 -0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.01 0.03 0.07 0.08 0.084
FCF Margin Trend 0.08 0.06 0.00 -0.03 -0.07 -0.08 -0.03 -0.02 0.00 0.03 0.03 0.02 0.04 0.04 0.05 0.07 0.07 0.07 0.05 0.03 0.032
Sustainable Growth Rate 3.2% 7.1% 6.2% 4.7% 5.2% 3.7% 3.8% 5.0% 5.0% 6.9% 8.5% 9.5% 9.9% 9.6% 8.9% 9.8% 12.1% 13.6% 12.6% 15.4% 15.45%
Internal Growth Rate 1.5% 3.5% 3.2% 2.5% 2.7% 1.9% 2.0% 2.7% 2.7% 3.8% 4.9% 5.5% 5.7% 5.5% 5.2% 5.7% 7.1% 8.1% 7.5% 9.4% 9.35%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 4.28 1.88 1.80 1.89 1.35 1.83 2.18 1.97 2.33 1.92 1.57 1.40 1.44 1.64 1.85 1.88 1.71 1.66 1.57 1.22 1.222
FCF/OCF 0.78 0.78 0.70 0.60 0.49 0.44 0.60 0.66 0.67 0.69 0.68 0.63 0.67 0.67 0.71 0.75 0.77 0.82 0.80 0.79 0.793
FCF/Net Income snapshot only 0.969
OCF/EBITDA snapshot only 0.911
CapEx/Revenue 4.4% 3.9% 4.7% 5.0% 4.9% 5.4% 4.8% 4.6% 5.2% 5.3% 5.6% 6.3% 5.7% 6.1% 6.0% 5.3% 5.3% 4.4% 4.5% 4.4% 4.36%
CapEx/Depreciation snapshot only 1.326
Accruals Ratio -0.06 -0.03 -0.03 -0.02 -0.01 -0.02 -0.03 -0.03 -0.04 -0.03 -0.03 -0.02 -0.02 -0.03 -0.04 -0.05 -0.05 -0.05 -0.04 -0.02 -0.019
Sloan Accruals snapshot only 0.052
Cash Flow Adequacy snapshot only 4.829
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.03 $0.02 $0.01 $0.00 $0.02 $0.02 $0.02 $0.02 $0.00 $0.00 $0.00 $0.00
Payout Ratio 10.7% 5.1% 5.3% 6.8% 6.2% 8.4% 7.9% 6.1% 6.0% 3.3% 1.8% 0.8% 0.0% 1.3% 1.2% 1.1% 0.9% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 3.2% 3.5% 4.2% 6.0% 9.4% 10.5% 6.0% 4.7% 3.9% 2.5% 1.6% 0.9% 0.0% 1.2% 0.9% 0.8% 0.7% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 1.1% 52.2% 7.0% 13.2% 12.1% 16.4% 15.3% 6.1% 6.0% 3.3% 1.8% 5.3% 4.4% 5.8% 5.6% 1.1% 0.9% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0
Chowder Number 3.00 0.97 0.31 -0.02 -0.02 0.00 0.00 0.00 -0.25 -0.49 -0.75 -0.44 -0.18 0.64
Buyback Yield 0.8% 0.8% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.7% 0.7% -0.1% -0.1% -0.0% -0.0% -0.0% -0.2% -0.2% -0.2% -0.2% -0.0% -0.0% -0.0% -0.1% -0.2% -0.2% -0.2% -0.2% -0.3% -0.26%
Total Shareholder Return 0.8% 0.8% -0.0% 0.0% 0.1% 0.1% 0.0% -0.1% -0.1% -0.2% -0.2% -0.0% -0.0% -0.0% -0.0% -0.2% -0.2% -0.2% -0.2% -0.3% -0.26%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.06 0.91 0.97 0.89 0.80 0.75 0.61 0.63 0.60 0.65 0.80 0.82 0.85 0.81 0.81 0.82 0.83 0.85 0.85 0.95 0.949
Interest Burden (EBT/EBIT) 0.58 0.77 0.75 0.62 0.67 0.63 0.70 0.85 0.85 0.87 0.88 0.89 0.88 0.88 0.86 0.86 0.88 0.89 0.87 0.92 0.916
EBIT Margin 0.08 0.14 0.12 0.12 0.13 0.11 0.13 0.13 0.13 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.18 0.19 0.19 0.20 0.198
Asset Turnover 0.37 0.37 0.38 0.39 0.39 0.40 0.39 0.40 0.41 0.43 0.42 0.44 0.45 0.47 0.45 0.47 0.50 0.52 0.48 0.50 0.496
Equity Multiplier 2.10 2.10 1.97 1.97 1.97 1.97 1.89 1.89 1.89 1.89 1.83 1.83 1.83 1.83 1.82 1.82 1.82 1.82 1.81 1.81 1.806
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.37 $0.76 $0.72 $0.56 $0.61 $0.45 $0.48 $0.62 $0.63 $0.83 $1.08 $1.20 $1.23 $1.20 $1.24 $1.36 $1.68 $1.86 $1.93 $2.38 $2.38
Book Value/Share $10.70 $10.68 $11.57 $11.56 $11.56 $11.54 $12.18 $12.15 $12.07 $11.91 $13.06 $13.01 $12.99 $12.96 $14.61 $14.58 $14.58 $14.56 $16.20 $16.21 $17.58
Tangible Book/Share $-0.38 $-0.38 $-1.03 $-1.03 $-1.03 $-1.03 $-0.87 $-0.86 $-0.86 $-0.85 $-0.75 $-0.75 $-0.75 $-0.74 $-1.34 $-1.34 $-1.34 $-1.34 $-0.71 $-0.72 $-0.72
Revenue/Share $7.82 $7.99 $8.28 $8.46 $8.57 $8.73 $8.79 $9.02 $9.20 $9.33 $9.64 $9.93 $10.26 $10.70 $11.24 $11.76 $12.38 $12.94 $13.42 $13.79 $13.88
FCF/Share $1.22 $1.13 $0.92 $0.64 $0.41 $0.36 $0.64 $0.81 $0.98 $1.10 $1.15 $1.05 $1.19 $1.32 $1.64 $1.92 $2.22 $2.52 $2.42 $2.30 $2.32
OCF/Share $1.57 $1.44 $1.30 $1.06 $0.83 $0.83 $1.06 $1.23 $1.46 $1.60 $1.69 $1.67 $1.77 $1.97 $2.31 $2.55 $2.87 $3.09 $3.03 $2.90 $2.92
Cash/Share $1.21 $1.21 $1.34 $1.34 $1.34 $1.34 $0.64 $0.64 $0.64 $0.63 $0.59 $0.58 $0.58 $0.58 $0.28 $0.28 $0.28 $0.28 $1.37 $1.37 $1.03
EBITDA/Share $1.37 $1.85 $1.76 $1.78 $1.92 $1.74 $1.92 $1.96 $2.02 $2.25 $2.34 $2.46 $2.46 $2.51 $2.63 $2.78 $3.16 $3.36 $3.28 $3.19 $3.19
Debt/Share $6.66 $6.64 $6.58 $6.57 $6.57 $6.56 $6.44 $6.42 $6.37 $6.29 $6.43 $6.41 $6.40 $6.38 $7.48 $7.47 $7.46 $7.45 $8.30 $8.31 $8.31
Net Debt/Share $5.45 $5.44 $5.24 $5.23 $5.23 $5.23 $5.79 $5.78 $5.74 $5.66 $5.84 $5.82 $5.81 $5.80 $7.20 $7.19 $7.19 $7.18 $6.93 $6.94 $6.94
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 3.983
Altman Z-Prime snapshot only 6.679
Piotroski F-Score 7 7 8 7 6 5 6 8 8 8 7 7 6 7 6 7 7 7 8 8 8
Beneish M-Score -2.82 -2.81 -2.48 -2.41 -2.34 -2.37 -2.47 -2.51 -2.57 -2.54 -2.49 -2.44 -2.44 -2.51 -2.45 -2.52 -2.54 -2.56 -2.62 -2.47 -2.472
Ohlson O-Score snapshot only -9.452
Net-Net WC snapshot only $-6.96
EVA snapshot only $482485515.77
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA-
Credit Score 50.88 56.00 55.30 55.08 55.10 52.11 66.80 72.16 72.74 76.88 76.37 78.61 79.09 79.31 76.10 76.08 75.91 81.39 83.22 80.05 80.047
Credit Grade snapshot only 4
Credit Trend snapshot only 3.972
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 74
Sector Credit Rank snapshot only 78

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms